FlowAid Medical Technologies, a company based in New York City, won FDA clearance for its FA100 Sequential Continuous Contraction Device (SCCD). It’s designed to help promote blood circulation, reduce swelling, prevent atrophy, and lower the chances of venous thrombosis in post-surgical patients by electrically stimulating the calf muscles.